FDA Inspection 750125 — Aurobindo Pharma Ltd
The FDA completed an inspection of Aurobindo Pharma Ltd on Sep 8, 2011 in Medchal. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 1 citation was issued during this inspection. Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 8, 2011
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Medchal (India)
Additional details
Postmarket Adverse Drug Experience (PADE)
Citations
| ID | CFR | Description |
|---|---|---|
| 8906 | 21 CFR 314.81(b)(1)(i) | Mix-up |